This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
In: National Foundation for Cancer Research
María José Alonso and Libera Bio, awarded by the US National Foundation for Cancer Research with the third prize of the 2021 Salisbury Award Competition
May 26, 2021Founded by Professor Alonso, Libera Bio is a company developing a novel delivery vector of whole monoclonal antibodies to intracellular cancer targets otherwise deemed “undruggable”. The Salisbury Award Competition is designed to catalyze and advance promising cancer research innovations onto a path of commercialization and patient impact.
Read More